Ropes & Gray advised Galderma in its agreement to acquire ZO Skin Health for an enterprise value of $1.5 billion in an all-cash deal that expands the Swiss dermatology company’s physician-dispensed skincare portfolio in the US. The deal was announced on October 14.
The deal strengthens Galderma’s skincare portfolio, including its flagship Cetaphil and Alastin brands, and expands its reach among dermatologists, plastic surgeons and other aesthetic medicine professionals.
The Ropes & Gray team was led by private equity partner Janet Coscino and mergers & acquisitions partner Zach Blume and private equity associates Nicole Martinez and Jahkeem Wheatley, and included antitrust partners Ruchit Patel and Jonathan Klarfeld, health care partner Jamie Darch, tax partner Elaine Murphy, international risk partner Emerson Siegle, life sciences regulatory & compliance partner Josh Oyster, employment partner Jen Cormier, litigation & enforcement counsel Alison McLaughlin and Heather Sprague and employment, executive compensation & benefits counsel Christa Sanchez.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.